特比萘芬治疗念珠菌性外阴阴道炎疗效和安全性评价

目的观察特比萘芬治疗念珠菌性外阴阴道炎的疗效及安全性。方法选择本院念珠菌性外阴阴道炎患者,随机分为治疗组34例,口服特比萘芬250mg,1次/d;对照组31例,口服伊曲康唑200mg,1次/d。两组均连用10天。结果治疗组和对照组有效率分别为67.65%和87.10%,真菌清除率分别为82.35%和83.87%,两组有效率和真菌清除率比较差异均无显著性意义(P均>0.05)。结论口服特比萘芬治疗念珠菌性外阴阴道炎疗效肯定,安全性高。     

特比萘芬治疗复发性念珠菌性阴道炎56例临床观察

目的观察特比萘芬治疗复发性念珠菌性阴道炎的疗效.方法选择门诊复发性念珠菌性阴道炎患者,随机分为治疗组(口服特比萘芬)和对照组(口服酮康唑),各56例.治疗后2用、8周、12周,随访观察疗效.结果治疗组与对照组治疗效果比较,差异无显著性(χ2=0,P＞0.05),但不良反应明显较对照组轻.结论口服特比萘芬治疗复发性念珠菌性阴道炎效果良好.     

特比萘芬治疗复发性念珠菌性外阴阴道炎临床观察

目的观察特比萘芬治疗复发性念珠菌性外阴阴道炎的疗效。方法选择复发性念珠菌性外阴阴道炎患者,随机分为治疗组(口服特比萘芬)和对照组(口服酮康唑)各60例。治疗后2,8,12周,随访观察疗效。结果2周后,治疗组和对照组有效率分别为85.00%和82.00%,两组差异无显著性(χ2=0.573,P=0.903);8周和12周时两组的复发率比较差异亦无显著性(前者χ2=0.194,P=0.659;后者χ2=0.192,P=0.661);治疗组不良反应明显较对照组轻(χ2=4.728,P=0.03)。结论口服特比萘芬治疗复发性念珠菌性外阴阴道炎效果良好,不良反应少。     

特比萘芬治疗外阴阴道念珠菌病的疗效观察

目的观察特比萘芬与伊曲康唑治疗外阴阴道假丝酵母菌病(念珠菌性外阴阴道炎)的疗效。方法选择本院妇科门诊诊断为外阴阴道假丝酵母菌病患者120例,随机分为治疗组和对照组各60例,分别予口服特比萘芬250mg、伊曲康唑200mg均1次/d,连服2周。结果治疗组和对照组有效率分别为81.7%和83.3%,差异无显著性(P=0.901);两组不良反应发生率差异亦无显著性(P>0.05)。结论口服特比萘芬治疗外阴阴道假丝酵母菌病疗效良好,不良反应少。     

依巴斯丁氟康唑联合特比萘芬治疗念珠菌性龟头炎临床观察

目的观察依巴斯丁氟康唑联合特比萘芬外用治疗念珠菌性龟头炎疗效。方法 44例分为两组,治疗组22例口服依巴斯丁10mg,1次/d,氟康唑150mg,1次/w,同时外用特比萘芬乳膏,1次/d;对照组22例仅外用特比特萘芬乳膏,1次/d。疗程2周。结果治疗组和对照组的痊愈率分别为81.81%和45.45%,两组差异有显著性意义(χ2=6.29,P0.05);两组有效率分别为95.45%和59.09%,差异具有显著性意义(χ2=8.28,P0.01)。结论依巴斯丁氟康唑联合特比萘芬乳膏外用治疗念珠菌性龟头炎疗效显著。     

特比萘芬治疗糖尿病伴念珠菌性间擦疹33例疗效观察

目的:探讨口服和外用特比萘芬治疗糖尿病伴念珠菌性间擦疹临床疗效观察,以及口服特比萘芬后对糖尿病患者血糖的影响。方法:选择Ⅱ型糖尿病伴念珠菌性间擦疹患者66例,随机分成A组和B组各33例。A组口服特比萘芬250 mg,每日1次,连服14天;A、B两组同时均外用特比萘芬软膏,每日2次,连用14天后评判疗效。A组患者服药前、停药时查空腹血糖以及餐后2小时血糖并作记录。结果:停药时A组有效率81.8%,B组69.7%;停药4周后有效率A组84.8%,B组69.7%。两组有效率比较差异均无统计学意义。口服特比萘芬前后A组患者血糖变化差异无统计学意义。结论:口服和外用特比萘芬治疗糖尿病伴念珠菌性间擦疹治愈率高,疗效确切,安全性好。     

特比萘芬治疗念珠菌性阴道炎100例疗效观察

为观察特比萘芬治疗念珠菌性阴道炎疗效，选择念珠菌性阴道炎患者100例，口服特比萘芬250mg, 每日1次，连服2周，停药时及停药后4周、8周复诊，观察疗效。治疗前后作真菌镜检及培养，鉴定菌种，观察真菌清除率，并作抑菌实验，测定MIC值。结果口服特比萘芬治疗念珠菌性阴道炎，治愈率85％，总有效率达93％。口服特比萘芬治疗念珠菌性阴道炎疗效良好。     

特比萘芬治疗念珠菌性外阴阴道炎、龟头炎临床观察

为观察特比萘芬治疗念珠菌性外阴道炎、龟头炎的疗效及不良反应，采用特比萘芬0.25g，日1次，连服1周对23例包皮龟头炎、37例外阴阴道炎患者进行了治疗。结果：停药1周后，外阴阴道炎的有效率为97.30%，包皮龟头炎的有效率为100%；真菌清除率达96.67%。结果口服特比萘芬治疗念珠菌性外阴阴道炎、包皮龟头炎疗效显著。     

特比萘芬与伊曲康唑治疗念珠菌性阴道炎疗效比较

目的：比较特比萘芬与伊曲康唑治疗念珠菌性阴道炎的疗效。方法：134例患分为两组，治疗组作真菌镜检及培养，A组口服特比萘芬0．25g，1次／d，连服7d，B组口服伊曲康唑0．2g，1次／d，连服7d；停药时、停药2周后复诊、作真菌镜检，判定疗效。结果：A组停药时及2周后有效率分别为79．4％，85．3％；B组停经时及2周后有效率分别为81．8％，83．3％，两组比较有效率无显性差异(P＞0．05)。结论：特比萘芬与伊曲康唑均对念珠菌性阴道炎有较好的疗效。     

国产特比萘芬治疗甲真菌病40例疗效观察

目的:观察国产特比萘芬治疗甲真菌病的疗效;方法:将门诊确诊为甲真菌病的患者分为治疗组40例(口服特比萘芬)和对照组36例(口服伊曲康唑);结果:停药6个月后治疗组的指趾甲真菌病治愈率分别是84.1%和83.5%;有效率分别是98.4%和95.9%;对照组指趾甲真菌治愈率分别90.9%和88.3%,有效率分别为99.0%和97.9%,两组指趾甲真菌病治愈率比较差异无显著性(指甲2=2.19,趾甲2=1.67,均P>0.05);结论:国产特比萘芬治疗甲真菌病有较好疗效。     

Fibroblasts induce the assembly of the macromolecules of the basement membrane

The mechanism regulating the deposition of basement membrane components (BMCs) in a polymeric structure at the junction with the connective tissues is not yet understood. Cultures and cocultures of epithelial BMC-producing cells (L2 or PER cells) and fibroblasts were prepared in several experimental conditions and the organization of BMCs was studied by immunofluorescence. The pattern of BMCs in pure cultures of L2 or pulmonary epithelial rat (PER) cells consisted of intra- and extracellular granular deposits. At very high density, the cell contours were also underlined by a disrupted network of BMC deposits. A different fibrillar plexus--containing laminin, collagen type IV, and heparan-sulfate proteoglycan resistant to deoxycholate treatment and distant from the cell membrane--was observed in cocultures of L2 or PER cells with fibroblasts. Fibrils of fibronectin and/or collagen type I were most often dissociated from this plexus of BMCs. Similar results were obtained by adding a conditioned medium of L2 or PER cells to confluent fibroblasts, even when the cells were killed. Pure laminin also bound to the fibroblast layer. A coated film of fibronectin or polymeric collagen type I was unable to bind BMC provided by a conditioned medium. It is suggested that molecule(s) synthesized by fibroblasts and deposited in the pericellular matrix are involved in the assembly of BMCs.